product summary
company name :
Cell Signaling Technology
product type :
product name :
Phospho-Estrogen Receptor α (Ser118) (16J4) Mouse mAb
catalog :
quantity :
40 ul
price :
123 USD
clonality :
host :
antigen modification :
reactivity :
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
citations: 4
Published Application/Species/DilutionReference
  • western blot; human
Wong P, Yeoh C, Ahmad A, Chelala C, Gillett C, Speirs V, et al. Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer. Oncogene. 2014;33:4579-88 pubmed publisher
Antognelli C, Palumbo I, Aristei C, Talesa V. Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB. Br J Cancer. 2014;111:395-406 pubmed publisher
De Marco P, Bartella V, Vivacqua A, Lappano R, Santolla M, Morcavallo A, et al. Insulin-like growth factor-I regulates GPER expression and function in cancer cells. Oncogene. 2013;32:678-88 pubmed publisher
Sirianni R, Zolea F, Chimento A, Ruggiero C, Cerquetti L, Fallo F, et al. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. J Clin Endocrinol Metab. 2012;97:E2238-50 pubmed publisher
product information
Product-Name :
Phospho-Estrogen Receptor α (Ser118) (16J4) Mouse mAb
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
Nuclear Receptor Signaling
Shipping-Temp :
Storage-Temp :
Product-Type :
Monoclonal Antibody
MW :
Host :
Target :
ER-alpha (Ser118) phosphate
Primary-Protein :
Alt-Names :
DKFZp686N23123,ER,ER-alpha,ESR,ESR1,ESRA,Era,Estradiol receptor,Estrogen receptor,NR3A1,Nuclear receptor subfamily 3 group A member 1,estrogen receptor 1,estrogen receptor alpha delta 3*,4,5,6,7*/819-2 isoform,estrogen receptor alpha delta 4 +49 isoform,estrogen receptor alpha delta 4*,5,6,7*/654 isoform
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.